New COVID Treatment Bamlanivimab Could Help Death, Hospitalization Rates
The drug is bamlanivimab, a recent FDA-approved monoclonal antibody treatment. Similar in some ways to other treatments because it does not kill the virus, but messes with its ability to multiply.